Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 8 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

13%

1 trials in Phase 3/4

Results Transparency

0 of 2 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A

4(80.0%)

Phase 3

1(20.0%)

5Total

N/A(4)

Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials

NCT04314791Completed

Accuracy of Placenta Accreta Index in Diagnosing Placenta Accreta Spectrum

Role: lead

NCT04247204Not ApplicableUnknown

Assessment of Endometrial and Sub-endometrial Vascularity Before and After PRP Infusion in Frozen Embryo Transfer Cycles

Role: lead

NCT04229953Unknown

Accuracy of Three /Four-dimensional Ultrasound in Diagnosing Placenta Accreta Spectrum

Role: lead

NCT04208555Not ApplicableUnknown

Comparison of Boric Acid vs. Terconazole in Treatment of RVVC

Role: lead

NCT04210479Not ApplicableUnknown

Comparison of Bladder Filling vs. Non-Filling in Cesarean Hysterectomy for Placenta Percreta

Role: lead

NCT04021940Not ApplicableUnknown

Dose Adjusted vs. Fixed Dose Unilateral Laparoscopic Ovarian Drilling in PCOS Patients

Role: lead

NCT03777358Unknown

Three-dimensional Ultrasonography Versus Hysteroscopy in Evaluation of Uterine Cavity in Infertile Women

Role: lead

NCT03378791Phase 3Completed

Efficacy of Iron Bisglycinate in Treatment of Iron Deficiency Anemia in Pregnant Women

Role: lead

All 8 trials loaded